<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:source>Science Advances 8(8) (2022)</dc:source>
  <dc:description xml:lang="eng">The tumor-suppressor PTPN2 is diminished in a subset of triple-negative breast cancers (TNBCs). Paradoxically, PTPN2-deficiency in tumors or T cells in mice can facilitate T cell recruitment and/or activation to promote antitumor immunity. Here, we explored the therapeutic potential of targeting PTPN2 in tumor cells and T cells. PTPN2-deficiency in TNBC associated with T cell infiltrates and PD-L1 expression, whereas low PTPN2 associated with improved survival. PTPN2 deletion in murine mammary epithelial cells TNBC models, did not promote tumorigenicity but increased STAT-1-dependent T cell recruitment and PD-L1 expression to repress tumor growth and enhance the efficacy of anti-PD-1. Furthermore, the combined deletion of PTPN2 in tumors and T cells facilitated T cell recruitment and activation and further repressed tumor growth or ablated tumors already predominated by exhausted T cells. Thus, PTPN2-targeting in tumors and/or T cells facilitates T cell recruitment and/or alleviates inhibitory constraints on T cells to combat TNBC.</dc:description>
  <dc:publisher>American Association for the Advancement of Science</dc:publisher>
  <dc:title xml:lang="eng">PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer</dc:title>
  <dc:rights>CC BY-NC 4.0 International</dc:rights>
  <dc:rights>http://creativecommons.org/licenses/by-nc/4.0/</dc:rights>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>doi:10.1126/sciadv.abk3338</dc:identifier>
  <dc:identifier>https://phaidra.vetmeduni.ac.at/o:1787</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:date>2022</dc:date>
  <dc:subject xml:lang="eng">Protein-Tyrosine-Phosphatase; Tumor-Infiltrating Lymphocytes; Mediated Gene Deletion; Activation; Promotes; Obesity; Stat1; Expression; Generation; Relevance</dc:subject>
  <dc:creator>Goh, Pei Kee (Monash University / Peter MacCallum Cancer Centre)</dc:creator>
  <dc:creator>McLean, Catriona (Alfred Hospital)</dc:creator>
  <dc:creator>Zeissig, Mara N. (Monash University / Peter MacCallum Cancer Centre)</dc:creator>
  <dc:creator>Wiede, Florian (Monash University / Peter MacCallum Cancer Centre)</dc:creator>
  <dc:creator>Tiganis, Tony (Monash University / Peter MacCallum Cancer Centre)</dc:creator>
  <dc:creator>Humbert, Patrick O. (University of Melbourne / La Trobe University)</dc:creator>
  <dc:creator>Müller, Mathias (University of Veterinary Medicine Vienna)</dc:creator>
  <dc:creator>Loi, Sherene (Peter MacCallum Cancer Centre / University of Melbourne)</dc:creator>
  <dc:creator>Xu, Rachel (Monash University / Peter MacCallum Cancer Centre)</dc:creator>
  <dc:creator>Goode, Nathan (La Trobe University)</dc:creator>
  <dc:creator>Molloy, Tim (St. Vincent&#39;s Centre for Applied Medical Research)</dc:creator>
  <dc:creator>Britt, Kara L. (Peter MacCallum Cancer Centre / The University of Melbourne)</dc:creator>
  <dc:type xml:lang="eng">article</dc:type>
</oai_dc:dc>